Does PEGLOTICASE Cause Infusion site extravasation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Infusion site extravasation have been filed in association with PEGLOTICASE (Krystexxa). This represents 0.3% of all adverse event reports for PEGLOTICASE.
9
Reports of Infusion site extravasation with PEGLOTICASE
0.3%
of all PEGLOTICASE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Infusion site extravasation From PEGLOTICASE?
Of the 9 reports.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGLOTICASE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does PEGLOTICASE Cause?
Gout (487)
Blood uric acid increased (359)
Infusion related reaction (284)
Therapeutic response decreased (186)
Dyspnoea (153)
Urticaria (133)
Drug ineffective (131)
Nausea (119)
Pruritus (118)
Rash (116)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which PEGLOTICASE Alternatives Have Lower Infusion site extravasation Risk?
PEGLOTICASE vs PEGUNIGALSIDASE ALFA-IWXJ
PEGLOTICASE vs PEGVALIASE-PQPZ
PEGLOTICASE vs PEGVISOMANT
PEGLOTICASE vs PEGZEREPOETIN ALFA
PEGLOTICASE vs PEMBROLIZUMAB